Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

EPA Should Reissue the 2014 RFS Proposal Consistent with the Statute, BIO Says

It is imperative that the Environmental Protection Agency gets the administration of the annual Renewable Fuel Standard (RFS) renewable volume obligations (RVOs) back on track, BIO wrote today.

Solazyme CEO Jonathan S. Wolfson to Receive the 2015 BIO George Washington Carver Award

The Biotechnology Industry Organization (BIO) named Solazyme CEO and co-founder Jonathan S. Wolfson as the recipient of its 2015 George Washington Carver Award for innovation in industrial biotechnology. Wolfson will receive the award and give a brief talk at the upcoming BIO World Congress on Industrial Biotechnology in July in Montreal, Canada. 

BIO Submits Comments on Electronic Distribution of Prescribing Information NPRM

The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the Proposed Rule entitled “Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products.”

BIO and Aon Join Forces to Offer Members Executive Liability Protection through BIO Business Solutions


Washington Governor Inslee Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

Governor Inslee signed Senate Bill 5935 into law on Monday. The Washington Senate passed the legislation in April with a vote of 47-1, preceded by a vote of 96-1 on the same bill in the House.

BIO and Aon Join Forces to Offer Members Executive Liability Protection through BIO Business Solutions

By teaming up with Aon, we are able to offer our members state-of-the-art coverage enhancements specific for life sciences companies...

2015 BIO International Convention to Feature Expanded Innovation Zone with NIH and NSF Small Business Innovation Research Companies

Washington, D.C. (May 11, 2015) – The Biotechnology Industry Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR) funded early-stage biomedical companies in an expanded Innovation Zone at the 2015 BIO International Convention®. The Innovation Zone companies, focused on drug discovery, diagnostics and other therapeutic platform technologies, will have dedicated exhibit space and participate in BIO One-on-One Partnering™. Select companies will make 15-minute company presentations in the BIO Business Forum. The Innovation Zone will also feature six universities funded under the prestigious NSF Accelerating Innovation Research Program (AIR). This select group will demonstrate advanced biomedical prototypes that are very close to commercialization stage.  

BIO Submits Comments Re: CMS HCPCS Public Meeting

The Biotechnology Industry Organization (BIO) is pleased to provide comments in response to the May 7 Centers for Medicare and Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda for Drugs, Biologicals and Radiopharmaceuticals (“Public Meeting Agenda”).

BIO Comments to the EPA RVOs Docket ID No EPA-HQ-OAR-2013-0479

The Biotechnology Industry Organization (“BIO”) is pleased to have the opportunity today to comment on the U.S. Environmental Protection Agency’s (“EPA”) Proposed Rule on the 2014 Standards for the Renewable Fuel Standard (RFS) PrograM (“the proposed rule”) and the renewable volume obligations (RVO) for biofuels in 2014.

LanzaTech CEO Holmgren Selected to receive the 2015 BIO Rosalind Franklin Award

Washington, D.C. (May 08, 2015) – The Biotechnology Industry Organization (BIO)  announced today  that  Dr. Jennifer Holmgren, Chief Executive Officer of the innovative carbon recycling company LanzaTech, has been selected by a committee of her peers to be the recipient of the 2015 BIO Rosalind Franklin Award. The Rosalind Franklin Award was established by BIO to honor an outstanding woman in the field of industrial biotechnology.